Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth

Core Insights - Silo Pharma has initiated its first Bitcoin purchase as part of a broader crypto reserve strategy aimed at multi-chain asset growth [1][2] - The CEO of Silo Pharma expressed confidence in Bitcoin as a store of value and a hedge against market volatility, highlighting the company's commitment to digital asset investments [2] - Silo Pharma's portfolio includes various therapeutic programs targeting conditions such as PTSD, fibromyalgia, and CNS diseases, developed in collaboration with leading universities [3] Company Overview - Silo Pharma operates as a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company [3] - The company focuses on addressing underserved medical conditions, including stress-induced psychiatric disorders and chronic pain [3] - Silo's innovative programs include SPC-15 for PTSD and SP-26 for fibromyalgia, along with preclinical assets for Alzheimer's disease and multiple sclerosis [3]